Farmaceutica R (RMAH) — Net Asset Quality Index
Farmaceutica R (RMAH) has a Net Asset Quality Index of 21.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of RON384.68 Million minus total liabilities of RON303.69 Million yields net assets of RON80.99 Million. A higher index indicates a stronger, lower-leverage balance sheet. For live market cap and overall valuation, see market cap of Farmaceutica R.
Quality Index
Net Assets
Total Assets
Total Liabilities
Farmaceutica R Net Asset Quality Index Over Time (2020–2025)
This chart shows how Farmaceutica R's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the index stands at 21.1%, representing net assets of RON80.99 Million against total assets of RON384.68 Million RON. See Farmaceutica R (RMAH) net assets for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Farmaceutica R (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Farmaceutica R from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Also explore net asset growth rate of Farmaceutica R to track the company's year-over-year net asset growth rate.
| Year | Quality Index | Net Assets (RON) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 21.1% | RON80.99 Million | RON384.68 Million | RON303.69 Million | ▲ +1.1 pp |
| 2024 | 19.9% | RON74.94 Million | RON376.03 Million | RON301.09 Million | ▼ -2.5 pp |
| 2023 | 22.4% | RON70.86 Million | RON315.76 Million | RON244.90 Million | ▼ -1.5 pp |
| 2022 | 23.9% | RON68.43 Million | RON286.20 Million | RON217.77 Million | ▼ -3.3 pp |
| 2021 | 27.2% | RON68.22 Million | RON251.07 Million | RON182.85 Million | ▼ -5.5 pp |
| 2020 | 32.7% | RON79.83 Million | RON244.46 Million | RON164.63 Million | — |